280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial
暂无分享,去创建一个
M. Preusser | C. Singer | J. Furtner | R. Bartsch | G. Widhalm | T. Fuereder | A. Weltermann | A. Berghoff | A. Starzer | A. Ilhan-Mutlu | M. Marhold | K. Dieckmann | E. Bergen | C. Minichsdorfer | Z. Bago-Horvath | S. Roider-Schur | H. Forstner | B. Rottenmanner